Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cui Tang Granules for Common Cold Phase III Trial
CTR20181818Phase 3Active
- Sponsor
- 奇正藏药
- Start
- Nov 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cuitang granules in nasopharyngitis, sponsored by 奇正藏药. Started Nov 2018; status: active.
02
Drugs
Cuitang granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20181818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181818.